	Term	Overlap	P.value	Adjusted.P.value	Old.P.value	Old.Adjusted.P.value	Odds.Ratio	Combined.Score	Genes
1	regulation of apoptotic process (GO:0042981)	5/815	2.17713919486991e-06	0.000740227326255768	0	0	59.2067901234568	771.908457490089	GSK3B;JUN;NEK4;ABL1;NFKB1
2	regulation of cellular response to stress (GO:0080135)	3/104	4.70859854388002e-06	0.000800461752459603	0	0	147.712871287129	1811.86384068843	GSK3B;NEK4;ABL1
3	positive regulation of cell differentiation (GO:0045597)	3/194	3.05632776269855e-05	0.00296979562161558	0	0	77.7565445026178	808.334592006879	JUN;ABL1;NFKB1
4	negative regulation of transferase activity (GO:0051348)	2/30	4.54623569093605e-05	0.00296979562161558	0	0	285.214285714286	2851.75094279513	GSK3B;ABL1
5	positive regulation of cell-matrix adhesion (GO:0001954)	2/33	5.51543927422646e-05	0.00296979562161558	0	0	257.574193548387	2525.61134289348	GSK3B;ABL1
6	regulation of transcription, DNA-templated (GO:0006355)	5/1598	5.92680692622676e-05	0.00296979562161558	0	0	28.8763339610797	281.066059929406	JUN;NEK4;ABL1;FOXK2;NFKB1
7	regulation of response to DNA damage stimulus (GO:2001020)	2/36	6.57764051548737e-05	0.00296979562161558	0	0	234.811764705882	2261.0610369429	NEK4;ABL1
8	positive regulation of gene expression (GO:0010628)	4/771	6.98775440380136e-05	0.00296979562161558	0	0	33.4219904389396	319.807213075061	GSK3B;JUN;NEK4;NFKB1
9	positive regulation of cell-substrate adhesion (GO:0010811)	2/52	0.00013807555394688	0.0052161875935488	0	0	159.544	1417.98072929542	GSK3B;ABL1
10	positive regulation of protein binding (GO:0032092)	2/60	0.000184063588438579	0.00608890211819165	0	0	137.48275862069	1182.38324490863	GSK3B;ABL1
11	cellular response to reactive oxygen species (GO:0034614)	2/65	0.000216120604261985	0.00608890211819165	0	0	126.539682539683	1067.95366275566	JUN;ABL1
12	regulation of gene expression (GO:0010468)	4/1037	0.000221702787927816	0.00608890211819165	0	0	24.4724104549855	205.915092020704	GSK3B;ABL1;FOXK2;NFKB1
13	phosphorylation (GO:0016310)	3/386	0.000235672092951054	0.00608890211819165	0	0	38.4007832898172	320.76439845477	GSK3B;NEK4;ABL1
14	stress-activated protein kinase signaling cascade (GO:0031098)	2/70	0.000250719498984362	0.00608890211819165	0	0	117.205882352941	971.774572764675	NEK4;NFKB1
15	positive regulation of transcription, DNA-templated (GO:0045893)	4/1120	0.000298684462596676	0.00677018115219133	0	0	22.5531660692951	183.044266493918	JUN;NEK4;FOXK2;NFKB1
16	negative regulation of binding (GO:0051100)	2/82	0.000344089241095118	0.00731189637327126	0	0	99.565	793.991996106761	GSK3B;JUN
17	positive regulation of protein complex assembly (GO:0031334)	2/88	0.000396222954561481	0.00792445909122962	0	0	92.5906976744186	725.312330963059	GSK3B;JUN
18	protein phosphorylation (GO:0006468)	3/470	0.000420633450101673	0.00794529850192048	0	0	31.3586723768737	243.774440767512	GSK3B;NEK4;ABL1
19	regulation of cytoskeleton organization (GO:0051493)	2/95	0.000461617357104636	0.00826052112713559	0	0	85.5913978494624	657.408203890213	GSK3B;ABL1
20	positive regulation of nucleic acid-templated transcription (GO:1903508)	3/502	0.000510250915907658	0.00867426557043018	0	0	29.2995991983968	222.108774945049	JUN;NEK4;NFKB1
21	response to endoplasmic reticulum stress (GO:0034976)	2/106	0.000574286834965629	0.00929797732801494	0	0	76.4961538461538	570.843488941552	GSK3B;JUN
22	cellular response to oxidative stress (GO:0034599)	2/115	0.000675435909192625	0.0104385549602497	0	0	70.3716814159292	513.723990826479	JUN;ABL1
23	response to lipopolysaccharide (GO:0032496)	2/155	0.00122161222453237	0.0180586154930872	0	0	51.8692810457516	347.917549111024	JUN;NFKB1
24	protein autophosphorylation (GO:0046777)	2/175	0.00155316315640011	0.0189144585548724	0	0	45.8265895953757	296.381712201002	GSK3B;ABL1
25	Fc-epsilon receptor signaling pathway (GO:0038095)	2/182	0.00167830814361295	0.0189144585548724	0	0	44.0288888888889	281.34323732188	JUN;NFKB1
26	Fc receptor signaling pathway (GO:0038093)	2/183	0.00169656941481244	0.0189144585548724	0	0	43.7834254143646	279.300909425349	JUN;NFKB1
27	regulation of hyaluronan biosynthetic process (GO:1900125)	1/6	0.00209838728197325	0.0189144585548724	0	0	666.266666666667	4108.59082569121	NFKB1
28	regulation of NFAT protein import into nucleus (GO:0051532)	1/6	0.00209838728197325	0.0189144585548724	0	0	666.266666666667	4108.59082569121	GSK3B
29	negative regulation of phospholipase activity (GO:0010519)	1/6	0.00209838728197325	0.0189144585548724	0	0	666.266666666667	4108.59082569121	ABL1
30	positive regulation of protein localization to centrosome (GO:1904781)	1/6	0.00209838728197325	0.0189144585548724	0	0	666.266666666667	4108.59082569121	GSK3B
31	regulation of extent of cell growth (GO:0061387)	1/6	0.00209838728197325	0.0189144585548724	0	0	666.266666666667	4108.59082569121	ABL1
32	negative regulation of glycogen biosynthetic process (GO:0045719)	1/6	0.00209838728197325	0.0189144585548724	0	0	666.266666666667	4108.59082569121	GSK3B
33	negative regulation of sterol transport (GO:0032372)	1/6	0.00209838728197325	0.0189144585548724	0	0	666.266666666667	4108.59082569121	NFKB1
34	regulation of canonical Wnt signaling pathway (GO:0060828)	2/213	0.0022886874342999	0.0189144585548724	0	0	37.5014218009479	228.000274177557	GSK3B;NFKB1
35	regulation of cell cycle (GO:0051726)	2/215	0.00233119177456319	0.0189144585548724	0	0	37.1455399061033	225.153071127976	JUN;NEK4
36	positive regulation of transcription from RNA polymerase II promoter (GO:0045944)	3/848	0.00233841669678208	0.0189144585548724	0	0	16.9952662721893	102.96210221265	JUN;FOXK2;NFKB1
37	regulation of vitamin D biosynthetic process (GO:0060556)	1/7	0.0024477534600423	0.0189144585548724	0	0	555.194444444444	3338.15358342286	NFKB1
38	regulation of calcidiol 1-monooxygenase activity (GO:0060558)	1/7	0.0024477534600423	0.0189144585548724	0	0	555.194444444444	3338.15358342286	NFKB1
39	ER overload response (GO:0006983)	1/7	0.0024477534600423	0.0189144585548724	0	0	555.194444444444	3338.15358342286	GSK3B
40	regulation of microtubule binding (GO:1904526)	1/7	0.0024477534600423	0.0189144585548724	0	0	555.194444444444	3338.15358342286	ABL1
41	negative regulation of glycogen metabolic process (GO:0070874)	1/7	0.0024477534600423	0.0189144585548724	0	0	555.194444444444	3338.15358342286	GSK3B
42	regulation of glycogen (starch) synthase activity (GO:2000465)	1/7	0.0024477534600423	0.0189144585548724	0	0	555.194444444444	3338.15358342286	GSK3B
43	regulation of Cdc42 protein signal transduction (GO:0032489)	1/7	0.0024477534600423	0.0189144585548724	0	0	555.194444444444	3338.15358342286	ABL1
44	regulation of protein localization to centrosome (GO:1904779)	1/7	0.0024477534600423	0.0189144585548724	0	0	555.194444444444	3338.15358342286	GSK3B
45	activation of protein kinase activity (GO:0032147)	2/233	0.00273062567328337	0.0194078593717494	0	0	34.2199134199134	202.00783168838	NEK4;ABL1
46	negative regulation of monooxygenase activity (GO:0032769)	1/8	0.00279701502710506	0.0194078593717494	0	0	475.857142857143	2797.66050021554	NFKB1
47	DNA damage induced protein phosphorylation (GO:0006975)	1/8	0.00279701502710506	0.0194078593717494	0	0	475.857142857143	2797.66050021554	ABL1
48	cellular response to angiotensin (GO:1904385)	1/8	0.00279701502710506	0.0194078593717494	0	0	475.857142857143	2797.66050021554	NFKB1
49	regulation of type B pancreatic cell development (GO:2000074)	1/8	0.00279701502710506	0.0194078593717494	0	0	475.857142857143	2797.66050021554	GSK3B
50	response to dopamine (GO:1903350)	1/9	0.00314617197276363	0.0204892458794872	0	0	416.354166666667	2398.8531813702	ABL1
51	cellular response to dopamine (GO:1903351)	1/9	0.00314617197276363	0.0204892458794872	0	0	416.354166666667	2398.8531813702	ABL1
52	negative regulation of alcohol biosynthetic process (GO:1902931)	1/9	0.00314617197276363	0.0204892458794872	0	0	416.354166666667	2398.8531813702	NFKB1
53	positive regulation of programmed cell death (GO:0043068)	2/257	0.003310147582869	0.0204892458794872	0	0	30.961568627451	176.814165170832	JUN;ABL1
54	negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201)	1/10	0.003495224297089	0.0204892458794872	0	0	370.074074074074	2093.27134911451	JUN
55	regulation of phospholipase C activity (GO:1900274)	1/10	0.003495224297089	0.0204892458794872	0	0	370.074074074074	2093.27134911451	ABL1
56	positive regulation of lipid localization (GO:1905954)	1/10	0.003495224297089	0.0204892458794872	0	0	370.074074074074	2093.27134911451	NFKB1
57	negative regulation of cholesterol transport (GO:0032375)	1/10	0.003495224297089	0.0204892458794872	0	0	370.074074074074	2093.27134911451	NFKB1
58	regulation of DNA-templated transcription, initiation (GO:2000142)	1/10	0.003495224297089	0.0204892458794872	0	0	370.074074074074	2093.27134911451	JUN
59	regulation of programmed cell death (GO:0043067)	2/268	0.00359352563385729	0.0207084528052793	0	0	29.6646616541353	166.971152011388	NEK4;ABL1
60	cellular response to oxygen-containing compound (GO:1901701)	2/274	0.00375276789361166	0.0209494751757516	0	0	29.0014705882353	161.980800202773	JUN;NFKB1
61	cellular protein modification process (GO:0006464)	3/1001	0.00375858231094368	0.0209494751757516	0	0	14.2747995991984	79.7063903416828	GSK3B;NEK4;ABL1
62	negative regulation of protein localization to nucleus (GO:1900181)	1/11	0.00384417200458596	0.0210809432509553	0	0	333.05	1852.15667504623	GSK3B
63	response to interleukin-6 (GO:0070741)	1/12	0.00419301510496052	0.021600380843736	0	0	302.757575757576	1657.3964565725	NFKB1
64	negative regulation of epithelial cell differentiation (GO:0030857)	1/12	0.00419301510496052	0.021600380843736	0	0	302.757575757576	1657.3964565725	GSK3B
65	cellular glucan metabolic process (GO:0006073)	1/12	0.00419301510496052	0.021600380843736	0	0	302.757575757576	1657.3964565725	GSK3B
66	negative regulation by host of viral transcription (GO:0043922)	1/12	0.00419301510496052	0.021600380843736	0	0	302.757575757576	1657.3964565725	JUN
67	negative regulation of ubiquitin-protein transferase activity (GO:0051444)	1/13	0.00454175360916762	0.0223796554654636	0	0	277.513888888889	1497.03260111151	ABL1
68	regulation of cell aging (GO:0090342)	1/13	0.00454175360916762	0.0223796554654636	0	0	277.513888888889	1497.03260111151	NEK4
69	regulation of oxidoreductase activity (GO:0051341)	1/13	0.00454175360916762	0.0223796554654636	0	0	277.513888888889	1497.03260111151	ABL1
70	positive regulation of apoptotic process (GO:0043065)	2/307	0.00468703726001153	0.0227656095486274	0	0	25.8203278688525	138.473246386889	JUN;ABL1
71	regulation of lymphocyte differentiation (GO:0045619)	1/14	0.0048903875335644	0.022776528108137	0	0	256.153846153846	1362.86237043318	ABL1
72	positive regulation of vascular smooth muscle cell proliferation (GO:1904707)	1/14	0.0048903875335644	0.022776528108137	0	0	256.153846153846	1362.86237043318	JUN
73	regulation of synapse organization (GO:0050807)	1/14	0.0048903875335644	0.022776528108137	0	0	256.153846153846	1362.86237043318	ABL1
74	positive regulation of protein export from nucleus (GO:0046827)	1/15	0.00523891689414434	0.022776528108137	0	0	237.845238095238	1249.0776854949	GSK3B
75	cellular response to DNA damage stimulus (GO:0006974)	2/329	0.0053642334460144	0.022776528108137	0	0	24.0562691131498	125.766218071523	NEK4;ABL1
76	positive regulation of macrophage derived foam cell differentiation (GO:0010744)	1/16	0.00558734170782148	0.022776528108137	0	0	221.977777777778	1151.45459385024	NFKB1
77	negative regulation of steroid biosynthetic process (GO:0010894)	1/16	0.00558734170782148	0.022776528108137	0	0	221.977777777778	1151.45459385024	NFKB1
78	positive regulation of DNA-templated transcription, initiation (GO:2000144)	1/16	0.00558734170782148	0.022776528108137	0	0	221.977777777778	1151.45459385024	JUN
79	platelet-derived growth factor receptor signaling pathway (GO:0048008)	1/17	0.00593566199512446	0.022776528108137	0	0	208.09375	1066.85019229932	ABL1
80	positive regulation by host of viral transcription (GO:0043923)	1/17	0.00593566199512446	0.022776528108137	0	0	208.09375	1066.85019229932	JUN
81	positive regulation of nitrogen compound metabolic process (GO:0051173)	1/17	0.00593566199512446	0.022776528108137	0	0	208.09375	1066.85019229932	NFKB1
82	negative regulation of cell development (GO:0010721)	1/17	0.00593566199512446	0.022776528108137	0	0	208.09375	1066.85019229932	GSK3B
83	positive regulation of focal adhesion assembly (GO:0051894)	1/17	0.00593566199512446	0.022776528108137	0	0	208.09375	1066.85019229932	ABL1
84	negative regulation of phosphoprotein phosphatase activity (GO:0032515)	1/17	0.00593566199512446	0.022776528108137	0	0	208.09375	1066.85019229932	GSK3B
85	response to purine-containing compound (GO:0014074)	1/17	0.00593566199512446	0.022776528108137	0	0	208.09375	1066.85019229932	JUN
86	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028)	1/17	0.00593566199512446	0.022776528108137	0	0	208.09375	1066.85019229932	GSK3B
87	positive regulation of metabolic process (GO:0009893)	1/18	0.0062838777740326	0.022776528108137	0	0	195.843137254902	992.879272061154	ABL1
88	positive regulation of actin cytoskeleton reorganization (GO:2000251)	1/18	0.0062838777740326	0.022776528108137	0	0	195.843137254902	992.879272061154	ABL1
89	regulation of microtubule polymerization or depolymerization (GO:0031110)	1/18	0.0062838777740326	0.022776528108137	0	0	195.843137254902	992.879272061154	ABL1
90	response to organophosphorus (GO:0046683)	1/18	0.0062838777740326	0.022776528108137	0	0	195.843137254902	992.879272061154	JUN
91	positive regulation of carbohydrate metabolic process (GO:0045913)	1/18	0.0062838777740326	0.022776528108137	0	0	195.843137254902	992.879272061154	NFKB1
92	negative regulation of protein dephosphorylation (GO:0035308)	1/18	0.0062838777740326	0.022776528108137	0	0	195.843137254902	992.879272061154	GSK3B
93	regulation of long-term synaptic potentiation (GO:1900271)	1/19	0.00663198906678106	0.022776528108137	0	0	184.953703703704	927.700128994203	ABL1
94	excitatory postsynaptic potential (GO:0060079)	1/19	0.00663198906678106	0.022776528108137	0	0	184.953703703704	927.700128994203	GSK3B
95	positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895)	1/19	0.00663198906678106	0.022776528108137	0	0	184.953703703704	927.700128994203	JUN
96	extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192)	1/19	0.00663198906678106	0.022776528108137	0	0	184.953703703704	927.700128994203	GSK3B
97	positive regulation of oxidoreductase activity (GO:0051353)	1/19	0.00663198906678106	0.022776528108137	0	0	184.953703703704	927.700128994203	ABL1
98	positive regulation of adherens junction organization (GO:1903393)	1/19	0.00663198906678106	0.022776528108137	0	0	184.953703703704	927.700128994203	ABL1
99	positive regulation of lipid storage (GO:0010884)	1/19	0.00663198906678106	0.022776528108137	0	0	184.953703703704	927.700128994203	NFKB1
100	regulation of cholesterol transport (GO:0032374)	1/20	0.00697999589418079	0.0234970158814007	0	0	175.210526315789	869.868917789248	NFKB1
101	regulation of glycogen biosynthetic process (GO:0005979)	1/20	0.00697999589418079	0.0234970158814007	0	0	175.210526315789	869.868917789248	GSK3B
102	energy reserve metabolic process (GO:0006112)	1/21	0.00732789827728551	0.0239565905218949	0	0	166.441666666667	818.238307210298	GSK3B
103	cellular response to alkaloid (GO:0071312)	1/21	0.00732789827728551	0.0239565905218949	0	0	166.441666666667	818.238307210298	NFKB1
104	response to nicotine (GO:0035094)	1/21	0.00732789827728551	0.0239565905218949	0	0	166.441666666667	818.238307210298	NFKB1
105	beta-catenin destruction complex disassembly (GO:1904886)	1/22	0.00767569624028282	0.0241411728621304	0	0	158.507936507937	771.885507856029	GSK3B
106	regulation of microtubule cytoskeleton organization (GO:0070507)	1/23	0.00802338980417862	0.0241411728621304	0	0	151.295454545455	730.06022058339	GSK3B
107	positive regulation of cell junction assembly (GO:1901890)	1/23	0.00802338980417862	0.0241411728621304	0	0	151.295454545455	730.06022058339	ABL1
108	cellular response to interleukin-6 (GO:0071354)	1/23	0.00802338980417862	0.0241411728621304	0	0	151.295454545455	730.06022058339	NFKB1
109	cellular response to catecholamine stimulus (GO:0071870)	1/23	0.00802338980417862	0.0241411728621304	0	0	151.295454545455	730.06022058339	ABL1
110	cellular response to ammonium ion (GO:0071242)	1/23	0.00802338980417862	0.0241411728621304	0	0	151.295454545455	730.06022058339	ABL1
111	negative regulation of viral transcription (GO:0032897)	1/23	0.00802338980417862	0.0241411728621304	0	0	151.295454545455	730.06022058339	JUN
112	negative regulation of transcription factor import into nucleus (GO:0042992)	1/23	0.00802338980417862	0.0241411728621304	0	0	151.295454545455	730.06022058339	GSK3B
113	cellular response to amyloid-beta (GO:1904646)	1/23	0.00802338980417862	0.0241411728621304	0	0	151.295454545455	730.06022058339	GSK3B
114	negative regulation of programmed cell death (GO:0043069)	2/408	0.00814591300094357	0.0242948282484282	0	0	19.2975369458128	92.8257638516735	GSK3B;NFKB1
115	membrane protein intracellular domain proteolysis (GO:0031293)	1/24	0.00837097899164431	0.0245356280789575	0	0	144.710144927536	692.146371059557	NFKB1
116	regulation of cellular senescence (GO:2000772)	1/24	0.00837097899164431	0.0245356280789575	0	0	144.710144927536	692.146371059557	NEK4
117	signal transduction in response to DNA damage (GO:0042770)	1/25	0.0087184638276748	0.0247023141784119	0	0	138.673611111111	657.633560998	ABL1
118	regulation of vascular smooth muscle cell proliferation (GO:1904705)	1/25	0.0087184638276748	0.0247023141784119	0	0	138.673611111111	657.633560998	JUN
119	negative regulation of cellular protein localization (GO:1903828)	1/25	0.0087184638276748	0.0247023141784119	0	0	138.673611111111	657.633560998	GSK3B
120	response to amyloid-beta (GO:1904645)	1/25	0.0087184638276748	0.0247023141784119	0	0	138.673611111111	657.633560998	GSK3B
121	regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893)	1/26	0.00906584433411521	0.0250600575089363	0	0	133.12	626.09548144397	JUN
122	regulation of microtubule-based process (GO:0032886)	1/26	0.00906584433411521	0.0250600575089363	0	0	133.12	626.09548144397	GSK3B
123	regulation of supramolecular fiber organization (GO:1902903)	1/26	0.00906584433411521	0.0250600575089363	0	0	133.12	626.09548144397	ABL1
124	modulation by host of viral transcription (GO:0043921)	1/27	0.00941312053617665	0.0254004839865084	0	0	127.99358974359	597.173389417304	JUN
125	positive regulation of substrate adhesion-dependent cell spreading (GO:1900026)	1/27	0.00941312053617665	0.0254004839865084	0	0	127.99358974359	597.173389417304	ABL1
126	regulation of protein localization to nucleus (GO:1900180)	1/27	0.00941312053617665	0.0254004839865084	0	0	127.99358974359	597.173389417304	GSK3B
127	cellular response to hydrogen peroxide (GO:0070301)	1/28	0.00976029245561303	0.0259257768352221	0	0	123.246913580247	570.56331831325	ABL1
128	dopamine receptor signaling pathway (GO:0007212)	1/28	0.00976029245561303	0.0259257768352221	0	0	123.246913580247	570.56331831325	GSK3B
129	manganese ion binding (GO:0030145)	2/35	6.21324902344407e-05	0.00345684313828838	0	0	241.939393939394	2343.48340136577	NEK4;ABL1
130	RNA polymerase II distal enhancer sequence-specific DNA binding (GO:0000980)	2/52	0.00013807555394688	0.00345684313828838	0	0	159.544	1417.98072929542	JUN;NFKB1
131	transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding (GO:0003705)	2/64	0.00020950564474475	0.00345684313828838	0	0	128.587096774194	1089.23041980736	JUN;NFKB1
132	enhancer sequence-specific DNA binding (GO:0001158)	2/64	0.00020950564474475	0.00345684313828838	0	0	128.587096774194	1089.23041980736	JUN;NFKB1
133	RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977)	3/460	0.000394896902424535	0.00521263911200387	0	0	32.0612691466083	251.260505983941	JUN;FOXK2;NFKB1
134	protein kinase activity (GO:0004672)	3/513	0.000543692184789486	0.00598061403268435	0	0	28.6514705882353	215.376751974283	GSK3B;NEK4;ABL1
135	RNA polymerase II transcription factor binding (GO:0001085)	2/121	0.000747331283269602	0.00678796806422968	0	0	66.8033613445378	480.917531002551	GSK3B;JUN
136	magnesium ion binding (GO:0000287)	2/127	0.000822784007785416	0.00678796806422968	0	0	63.5776	451.58004771743	ABL1;FOXK2
137	cAMP response element binding (GO:0035497)	1/7	0.0024477534600423	0.012489822425211	0	0	555.194444444444	3338.15358342286	JUN
138	regulatory region DNA binding (GO:0000975)	2/224	0.00252711467965086	0.012489822425211	0	0	35.6234234234234	213.052191618675	JUN;NFKB1
139	DNA binding (GO:0003677)	3/893	0.00271242139019295	0.012489822425211	0	0	16.0980337078652	95.13798739535	JUN;ABL1;FOXK2
140	phosphotransferase activity, alcohol group as acceptor (GO:0016773)	2/254	0.00323479338323943	0.012489822425211	0	0	31.3349206349206	179.6678615511	GSK3B;ABL1
141	RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)	2/262	0.0034375786413119	0.012489822425211	0	0	30.3584615384615	172.223186147566	JUN;FOXK2
142	tau-protein kinase activity (GO:0050321)	1/10	0.003495224297089	0.012489822425211	0	0	370.074074074074	2093.27134911451	GSK3B
143	protein heterodimerization activity (GO:0046982)	2/265	0.00351513957526952	0.012489822425211	0	0	30.0076045627376	169.56325230166	JUN;NFKB1
144	dynactin binding (GO:0034452)	1/11	0.00384417200458596	0.012489822425211	0	0	333.05	1852.15667504623	GSK3B
145	core promoter proximal region sequence-specific DNA binding (GO:0000987)	2/278	0.00386075494292475	0.012489822425211	0	0	28.5753623188406	158.790217513345	JUN;FOXK2
146	transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding (GO:0000982)	2/280	0.00391529497085441	0.012489822425211	0	0	28.3669064748201	157.233921954999	JUN;FOXK2
147	kinase activity (GO:0016301)	2/280	0.00391529497085441	0.012489822425211	0	0	28.3669064748201	157.233921954999	GSK3B;ABL1
148	ubiquitin protein ligase binding (GO:0031625)	2/284	0.00402546610380129	0.012489822425211	0	0	27.9588652482269	154.196345164681	GSK3B;JUN
149	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding (GO:0001228)	2/284	0.00402546610380129	0.012489822425211	0	0	27.9588652482269	154.196345164681	FOXK2;NFKB1
150	transcriptional repressor activity, RNA polymerase II activating transcription factor binding (GO:0098811)	1/12	0.00419301510496052	0.012489822425211	0	0	302.757575757576	1657.3964565725	JUN
151	ubiquitin-like protein ligase binding (GO:0044389)	2/297	0.00439353557279654	0.012489822425211	0	0	26.7091525423729	144.967157401421	GSK3B;JUN
152	protein kinase A catalytic subunit binding (GO:0034236)	1/13	0.00454175360916762	0.012489822425211	0	0	277.513888888889	1497.03260111151	GSK3B
153	transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding (GO:0001205)	1/18	0.0062838777740326	0.0148606364198688	0	0	195.843137254902	992.879272061154	NFKB1
154	neuropilin binding (GO:0038191)	1/19	0.00663198906678106	0.0148606364198688	0	0	184.953703703704	927.700128994203	ABL1
155	R-SMAD binding (GO:0070412)	1/19	0.00663198906678106	0.0148606364198688	0	0	184.953703703704	927.700128994203	JUN
156	ephrin receptor binding (GO:0046875)	1/19	0.00663198906678106	0.0148606364198688	0	0	184.953703703704	927.700128994203	ABL1
157	protein serine/threonine kinase activity (GO:0004674)	2/368	0.00666979976127984	0.0148606364198688	0	0	21.4502732240437	107.469417592158	GSK3B;NEK4
158	transcription regulatory region DNA binding (GO:0044212)	2/374	0.0068824396484092	0.0148606364198688	0	0	21.0978494623656	105.041595037222	JUN;NFKB1
159	mitogen-activated protein kinase binding (GO:0051019)	1/20	0.00697999589418079	0.0148606364198688	0	0	175.210526315789	869.868917789248	ABL1
160	adenylyltransferase activity (GO:0070566)	1/21	0.00732789827728551	0.0151137901969014	0	0	166.441666666667	818.238307210298	ABL1
161	actinin binding (GO:0042805)	1/22	0.00767569624028282	0.0151447439491926	0	0	158.507936507937	771.885507856029	NFKB1
162	transition metal ion binding (GO:0046914)	2/399	0.0078018377920083	0.0151447439491926	0	0	19.744080604534	95.8258410138828	NEK4;ABL1
163	NF-kappaB binding (GO:0051059)	1/24	0.00837097899164431	0.0157852746699578	0	0	144.710144927536	692.146371059557	GSK3B
164	actin monomer binding (GO:0003785)	1/25	0.0087184638276748	0.0159838503507371	0	0	138.673611111111	657.633560998	ABL1
165	SH2 domain binding (GO:0042169)	1/26	0.00906584433411521	0.0161715061095028	0	0	133.12	626.09548144397	ABL1
166	metal ion binding (GO:0046872)	2/442	0.00950753409109559	0.0165130855266397	0	0	17.7754545454545	82.7566634834943	ABL1;FOXK2
167	nuclear euchromatin (GO:0005719)	1/18	0.0062838777740326	0.0806068810501406	0	0	195.843137254902	992.879272061154	JUN
168	euchromatin (GO:0000791)	1/21	0.00732789827728551	0.0806068810501406	0	0	166.441666666667	818.238307210298	JUN
169	Neurotrophin signaling pathway	4/119	4.11228977901758e-08	3.9066752900667e-06	0	0	230.469565217391	3919.5269268815	GSK3B;JUN;ABL1;NFKB1
170	B cell receptor signaling pathway	3/71	1.48516935979402e-06	7.05455445902158e-05	0	0	219.761029411765	2949.18900301513	GSK3B;JUN;NFKB1
171	ErbB signaling pathway	3/85	2.56115279460832e-06	7.982037806401e-05	0	0	182.112804878049	2344.7120312535	GSK3B;JUN;ABL1
172	IL-17 signaling pathway	3/93	3.36085802374779e-06	7.982037806401e-05	0	0	165.858333333333	2090.36469637573	GSK3B;JUN;NFKB1
173	T cell receptor signaling pathway	3/101	4.31095121738799e-06	8.19080731303719e-05	0	0	152.257653061224	1881.04463727922	GSK3B;JUN;NFKB1
174	Measles	3/138	1.1024030328904e-05	0.000174547146874313	0	0	110.322222222222	1259.37594639659	GSK3B;JUN;NFKB1
175	Non-alcoholic fatty liver disease (NAFLD)	3/149	1.38754940961277e-05	0.000188310277018876	0	0	101.953767123288	1140.39226883502	GSK3B;JUN;NFKB1
176	Pathways in cancer	4/530	1.60155535036407e-05	0.000190184697855733	0	0	49.3460076045627	544.876159225513	GSK3B;JUN;ABL1;NFKB1
177	Influenza A	3/171	2.09592861558149e-05	0.000221236909422491	0	0	88.5044642857143	953.452288386002	GSK3B;JUN;NFKB1
178	Kaposi sarcoma-associated herpesvirus infection	3/186	2.69504370706421e-05	0.0002560291521711	0	0	81.1885245901639	854.225958032671	GSK3B;JUN;NFKB1
179	Cocaine addiction	2/49	0.000122517327309275	0.00105810419039829	0	0	169.753191489362	1529.01080744086	JUN;NFKB1
180	Inflammatory bowel disease (IBD)	2/65	0.000216120604261985	0.00156002876073168	0	0	126.539682539683	1067.95366275566	JUN;NFKB1
181	Shigellosis	2/65	0.000216120604261985	0.00156002876073168	0	0	126.539682539683	1067.95366275566	ABL1;NFKB1
182	Epithelial cell signaling in Helicobacter pylori infection	2/68	0.000236575327494506	0.00156002876073168	0	0	120.769696969697	1008.33565467298	JUN;NFKB1
183	Prolactin signaling pathway	2/70	0.000250719498984362	0.00156002876073168	0	0	117.205882352941	971.774572764675	GSK3B;NFKB1
184	Leishmaniasis	2/74	0.000280224444748221	0.00156002876073168	0	0	110.672222222222	905.289889415916	JUN;NFKB1
185	Chronic myeloid leukemia	2/76	0.000295584396770213	0.00156002876073168	0	0	107.67027027027	874.988497599987	ABL1;NFKB1
186	Pertussis	2/76	0.000295584396770213	0.00156002876073168	0	0	107.67027027027	874.988497599987	JUN;NFKB1
187	Colorectal cancer	2/86	0.00037844252536808	0.00179760199549838	0	0	94.8047619047619	747.009034683811	GSK3B;JUN
188	Salmonella infection	2/86	0.00037844252536808	0.00179760199549838	0	0	94.8047619047619	747.009034683811	JUN;NFKB1
189	Th1 and Th2 cell differentiation	2/92	0.00043298934074385	0.00195876130336504	0	0	88.4577777777778	685.087571543488	JUN;NFKB1
190	Prostate cancer	2/97	0.000481203471822415	0.00202022359810085	0	0	83.7810526315789	640.02192295857	GSK3B;NFKB1
191	AGE-RAGE signaling pathway in diabetic complications	2/100	0.00051133277923463	0.00202022359810085	0	0	81.2040816326531	615.404316417306	JUN;NFKB1
192	Chagas disease (American trypanosomiasis)	2/103	0.000542361025370162	0.00202022359810085	0	0	78.780198019802	592.393897420189	JUN;NFKB1
193	Toll-like receptor signaling pathway	2/104	0.000552903300532864	0.00202022359810085	0	0	78.0039215686274	585.054952990065	JUN;NFKB1
194	C-type lectin receptor signaling pathway	2/104	0.000552903300532864	0.00202022359810085	0	0	78.0039215686274	585.054952990065	JUN;NFKB1
195	Th17 cell differentiation	2/107	0.00058512799250895	0.00202237586410752	0	0	75.7638095238095	563.961549437206	JUN;NFKB1
196	Insulin resistance	2/108	0.000596068675736952	0.00202237586410752	0	0	75.0452830188679	557.222833653302	GSK3B;NFKB1
197	TNF signaling pathway	2/110	0.000618248416001664	0.00202529653517786	0	0	73.6481481481482	544.158196104097	JUN;NFKB1
198	Cell cycle	2/124	0.000784613660254309	0.00248460992413864	0	0	65.1508196721311	465.849151186	GSK3B;ABL1
199	Osteoclast differentiation	2/127	0.000822784007785416	0.00252143486256821	0	0	63.5776	451.58004771743	JUN;NFKB1
200	Relaxin signaling pathway	2/130	0.000861840960503834	0.00255859035149576	0	0	62.078125	438.050552263465	JUN;NFKB1
201	Fluid shear stress and atherosclerosis	2/139	0.000984317813949517	0.00283364219167285	0	0	57.9737226277372	401.384647412394	JUN;NFKB1
202	Apoptosis	2/143	0.0010412997163339	0.00290951391328591	0	0	56.3177304964539	386.749940724219	JUN;NFKB1
203	Breast cancer	2/147	0.00109984489667705	0.00298529329098058	0	0	54.7531034482759	373.010232148318	GSK3B;JUN
204	Hepatitis C	2/155	0.00122161222453237	0.0032236989258493	0	0	51.8692810457516	347.917549111024	GSK3B;NFKB1
205	Wnt signaling pathway	2/158	0.00126887853971689	0.00325793138575958	0	0	50.8641025641026	339.24432771676	GSK3B;JUN
206	Hepatitis B	2/163	0.0013495941039709	0.00337398525992724	0	0	49.272049689441	325.587309502785	JUN;NFKB1
207	NOD-like receptor signaling pathway	2/178	0.00160622110058101	0.00391258986038965	0	0	45.0386363636364	289.772776439842	JUN;NFKB1
208	Axon guidance	2/181	0.0016601426267215	0.00394283873846355	0	0	44.277094972067	283.411121305891	GSK3B;ABL1
209	Chemokine signaling pathway	2/190	0.00182707526872737	0.0042334670860756	0	0	42.1382978723404	265.683603238372	GSK3B;NFKB1
210	Focal adhesion	2/199	0.00200173186333234	0.0044079778442252	0	0	40.194923857868	249.760908326322	GSK3B;JUN
211	Viral carcinogenesis	2/201	0.00204158973837799	0.0044079778442252	0	0	39.7869346733668	246.441327366147	JUN;NFKB1
212	Epstein-Barr virus infection	2/201	0.00204158973837799	0.0044079778442252	0	0	39.7869346733668	246.441327366147	JUN;NFKB1
213	Human immunodeficiency virus 1 infection	2/212	0.00226757657072375	0.00468303856997296	0	0	37.6819047619048	229.44676131864	JUN;NFKB1
214	cAMP signaling pathway	2/212	0.00226757657072375	0.00468303856997296	0	0	37.6819047619048	229.44676131864	JUN;NFKB1
215	Human T-cell leukemia virus 1 infection	2/219	0.00241732952873601	0.00488609160063662	0	0	36.4534562211982	219.635421933127	JUN;NFKB1
216	Human cytomegalovirus infection	2/225	0.00254935294585726	0.00504559437200916	0	0	35.4618834080717	211.775378231324	GSK3B;NFKB1
217	Ras signaling pathway	2/232	0.00270763973184581	0.0052495056025582	0	0	34.3704347826087	203.186942166432	ABL1;NFKB1
218	MAPK signaling pathway	2/295	0.0043359153486591	0.00823823916245228	0	0	26.8941979522184	146.326558358414	JUN;NFKB1
219	MicroRNAs in cancer	2/299	0.00445151634633622	0.00829204025297924	0	0	26.5265993265993	143.628550287688	ABL1;NFKB1
220	Human papillomavirus infection	2/330	0.00539603792856535	0.00985814621564824	0	0	23.9817073170732	125.234641437224	GSK3B;NFKB1
221	PI3K-Akt signaling pathway	2/354	0.00618580501644024	0.0110877637087136	0	0	22.3193181818182	113.504850772766	GSK3B;NFKB1
